Increasing Prevalence of Asthma and Emergence of Covid-19 to Augment Growth of Respiratory Drug Delivery Formulation Market
Respiratory drugs can be delivered to the body in different ways. The most common form is through inhalation. Oral or intravenous delivery are other common methods. Respiratory drugs are used for the treatment of different respiratory disorders. They include medicines for treatment of influenza, pneumonia, chronic obstructive pulmonary diseases, and some common forms of allergy such as food allergies and rhinitis. Market Dynamics Increasing prevalence of asthma is expected to propel growth of the global respiratory drug delivery formulation market. For instance, According to The Global Asthma Report 2018, around 300 million people have asthma worldwide, and the number is expected to reach 100 million by 2025. Moreover, initiatives to boost adoption of dry powder inhalers is also expected to aid in growth of the market. For instance, in September 2018, researchers from University of Helsinki, Finland, reported investigation of non-verbal, demonstrational videos as a me...